NCT03603704View on ClinicalTrials.gov

A Study of LY3209590 in Japanese Participants With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 17, 2018

Primary Completion Date

May 27, 2019

Study Completion Date

May 27, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

LY3209590

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (3)

192-0071

P-one clinic, Hachiōji

130-0004

Sumida Hospital, Sumida-ku

812-0025

Hakata Clinic, Fukuoka

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03603704 - A Study of LY3209590 in Japanese Participants With Type 2 Diabetes | Biotech Hunter | Biotech Hunter